Thielmann, Carl Maximilian
Costa da Silva, Milene
Muley, Thomas
Meister, Michael
Herpel, Esther
Muckenthaler, Martina U. http://orcid.org/0000-0002-3778-510X
Article History
Received: 13 November 2018
Accepted: 8 July 2019
First Online: 5 August 2019
Competing Interests
: Dr. Muley reports grants, personal fees and non-financial support from Roche, outside the submitted work; Prof. Muckenthaler reports other from Novartis Pharma Coop., other from Vifor Pharma Ltd, other from Silence Therapeutics PLC, other from Merck Selbstmedikation Consumer Health Care, outside the submitted work; the remaining authors declare no competing interests.